Updated CPG: Henoch-Schönlein purpura
Henoch-schönlein purpura was an existing Victorian CPG and was endorsed by PIC on 18 February 2021. The revision was considered by interstate reviewers.
Henoch-schönlein purpura was an existing Victorian CPG and was endorsed by PIC on 18 February 2021. The revision was considered by interstate reviewers.
Nasogastric fluids is a new CPG and was endorsed by PIC on 18 February 2021. The guideline was discussed by the CPG committee on 21 October 2020.
Gastroenteritis is an existing Victorian CPG and was endorsed by PIC on 18 February 2021. The guideline was discussed by the CPG committee on 5 November 2020.
Vomiting is a new CPG and was endorsed by PIC on 18 February 2021. The guideline was discussed by the CPG committee on 16 September 2020.
Sodium valproate poisoning was an existing Victorian CPG and was endorsed by PIC on 18 February 2021. The revision was considered by interstate reviewers.
Kawasaki Disease was an existing Victorian CPG and was endorsed by PIC on 18 February 2021. The revision was discussed by the CPG committee on 1 October 2020.
Febrile seizure was an existing Victorian CPG and was endorsed by PIC on 18 February 2021. The revision was considered by interstate reviewers.
Oral hypoglycaemic poisoning is a new CPG that was endorsed for Victorian use on 18 February 2021 and requires consideration by interstate reviewers before endorsement by PIC.
Acute otitis media was an existing Victorian CPG and was endorsed by PIC on 18 February 2021. The revision was considered by interstate reviewers.
Hypernatraemia was an existing Victorian CPG and was endorsed by PIC on 26 November 2020. The revision was discussed by the CPG committee on 19 August 2020.